Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo

Autor: Liu, WM, Hall, NK, Liu, HSY, Hood, FL, Dalgleish, AG

We previously reported that both cannabidiol (CBD) and low‑dose naltrexone (LDN) exhibit complex effects on G‑protein coupled receptors, which can impact the expression and function of other members of this superfamily. These receptors feed into

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::6594550996ffbac68f800241d36022f3

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pernicious anemia in Chinese: a study of 181 patients in a Hong Kong hospital.

Autor: Chan JCW, Liu HSY, Kho BCS, Sim JPY, Lau TKH, Luk YW, Chu RW, Cheung FMF, Choi FPT, Ma ESK, Chan, Joyce Chee Wun, Liu, Herman Sung Yu, Kho, Bonnie Chi Sang, Sim, Joycelyn Pui Yin, Lau, Thomas Kwan Hang, Luk, Yiu Wing, Chu, Raymond Wan, Cheung, Florence Man Fung, Choi, Frankie Pak Tat, Ma, Edmond Shiu Kwan

Publikováno v: Medicine; May2006, Vol. 85 Issue 3, p129-138, 10p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies.

Autor: Song Y; Peking University Cancer Hospital and Institute, Beijing, China., Wu SJ; Hematology Division, Department of Internal Medicine, National Taiwan University Hospital, Taiwan, China., Shen Z; Shanghai Jiaotong University Affiliated Ruijin Hospital, Shanghai, China., Zhao D; Harbin Hematology and Oncology Institute, Heilongjiang, 150007, China., Chan TSY; Department of Medicine, Queen Mary Hospital, Hong Kong, China., Huang H; Sun Yat-Sen University Cancer Center, Guangdong, China., Qiu L; Institute of Hematology and Blood Diseases Hospital, Tianjing, China., Li J; Jiangsu Provincial People's Hospital, Jiangsu, China., Tan TD; Department of Hematology and Medical Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taiwan, China., Zhu J; Peking University Cancer Hospital and Institute, Beijing, China., Song Y; The First Affiliated Hospital of Zhengzhou University, Henan, China., Huang WH; Department of Clinical Pathology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taiwan, China., Zhao W; Shanghai Jiaotong University Affiliated Ruijin Hospital, Shanghai, China., Liu HSY; Premier Medical Centre, Hong Kong, China., Xu W; Jiangsu Provincial People's Hospital, Jiangsu, China., Chen N; Macau Society of Hematology and Oncology, Macau, China., Ma J; Harbin Hematology and Oncology Institute, Heilongjiang, 150007, China. majun0322@126.com., Chang CS; Division of Hematology-Oncology, Department of Internal Medicine, Chang Bing Show Chwan Memorial Hospital, Taiwan, China. cs4816@gmail.com.; Department of Healthcare Administration, Central Taiwan University of Science and Technology, Taiwan, China. cs4816@gmail.com., Tse EWC; Department of Medicine, School of Clinical Medicine, University of Hong Kong, Hong Kong, China. ewctse@hku.hk.

Publikováno v: Experimental hematology & oncology [Exp Hematol Oncol] 2023 Oct 16; Vol. 12 (1), pp. 92. Date of Electronic Publication: 2023 Oct 16.